Pressemitteilungen
Ganz gleich, ob es um ein neues Produkt als Grundlage für wegweisende Forschung, eine strategische Partnerschaft mit einem Kunden oder eine gemeinnützige Partnerschaft im Zeichen unserer Vision geht: Bei uns gibt es immer Neues zu entdecken. Nachstehend finden Sie unsere neuesten Pressemitteilungen sowie Filtermöglichkeiten, um Ihre Suche weiter einzugrenzen.
Kontaktperson
Für Anfragen von Journalisten wenden Sie sich bitte ausschließlich an:
Rachel Bloom-Baglin
Telefon: +49 (6151) 72-44461
Apr 17, 2024
MilliporeSigma Inspires Students to Explore STEM Careers with 2024 Curiosity Cube TourMilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, a leading science and technology company, officially kicked off its global 2024 Curiosity Cube tour today in Darmstadt, Germany.
Apr 16, 2024
Merck Launches First All-in-One Genetic Stability Assay to Accelerate Biosafety TestingMerck, a leading science and technology company, has launched the first all-in-one, validated genetic stability assay of its kind.
Feb 13, 2024
Press Release Test AEM3-605Teaser text.
Nov 25, 2022
AEM2-823-PR - - Merck Announces Closing of Exelead Acquisition and Plans to Invest More Than € 500 Million in Technology Scale-UpMerck, the U.S. and Canada Life Science business sector of Merck KGaA, Darmstadt, Germany, a leading science and technology company, today announced the closing of the transaction to acquire Exelead, following regulatory clearances and the fulfillment of other customary closing conditions, for approximately USD 780 million in cash. The business combination is expected to enable the Life Science business to provide its customers with comprehensive end-to-end contract development and manufacturing organization (CDMO) services across the mRNA value chain. The Life Science business plans to further invest over € 500 million to scale up Exelead’s technology over the next ten years.
Nov 01, 2022
Jul 15, 2021
Press Release Merck 1606 Headline ROWPress Release Merck 1606 Headline ROW
Aug 19, 2019
Um weiterzulesen, melden Sie sich bitte an oder erstellen ein Konto.
Sie haben kein Konto?